WASHINGTON (AP) — Makers of medical tests that have long escaped government oversight will have about four years to show that their new offerings deliver accurate results, under a government rule vigorously opposed by the testing industry.
The regulation finalized Monday by the Food and Drug Administration will gradually phase in oversight of new tests developed by laboratories, a multibillion-dollar industry that regulators say poses growing risks to Americans. The goal is to ensure that new tests for cancer, heart disease, COVID-19, genetic conditions and many other illnesses are safe, accurate and reliable.
“The final rule announced today aims to provide crucial oversight of these tests to help ensure that important health care decisions are made based on test results that patients and health care providers can trust,” said FDA commissioner Robert Califf, in a release.
Mohammad Mokhber: Who is Iran’s acting president?
A former Maldives president is freed after a high court throws out his 11
Inside luxury brands' STAGGERING price hikes
Rybakina, Vondroušová into Stuttgart quarters while Jabeur out
Ship that caused Baltimore bridge collapse has been refloated
Jets might have a tough call to make between a playmaker or protection at No. 10 in the NFL draft
Fire in truck carrying lithium ion batteries leads to 3
A former Maldives president is freed after a high court throws out his 11
California congressman urges closer consultation with tribes on offshore wind
Temporary 911 outages reported in Nebraska, Texas and other states
Iran helicopter crash that killed President Raisi could reverberate across the Middle East
Gunman shot himself and wasn't killed by officer, chief says